HIV Treatment Bulletin - Vol. 5, No. 7, August/September 2004
Simon Collins, HIV i-Base
McCoombe and colleagues from University of Melbourne presented results of a study designed to determine where HIV enters the penis, hoping to understand the reported lower incidence of circumcised men in many African countries.
They studied the distribution of target cells in the glans penis, frenulum, foreskin and urethral meatus from five uncircumcised penises obtained at autopsy and measured the thickness of the overlying layer of keratin. Keratin potentially prevents HIV gaining access to these penile receptors.
Langerhans cells, dendritic cells, macrophages and T-cells and keratin thickness were studied using histochemical staining techniques and microscopy.
HIV target cells expressing CD4 and CCR5 were found in the inner and outer foreskin, frenulum and glans penis, but at lower levels in the urethral meatus and penile urethra. Dendritic cells, macrophages and T cells expressing these receptors were observed in high densities in the dermis of all regions of the penis except the urethra. HIV susceptible Langerhans cells in the inner foreskin and frenulum were closer to the epithelial surface, but less frequent than in the outer foreskin and glans.
There was little if any protective covering of keratin overlying the inner foreskin and frenulum (Langerhans cells were within 4.5um of the epithelial surface), in contrast to the glans penis and outer foreskin which were heavily keratinized and (rarely coming with 20um of the epithelial surface), thus protecting them from viral entry.
The study concluded that HIV is likely to enter the penis of uncircumcised men via superficial Langerhans cells on the inner aspect of the foreskin and frenulum since these sites are not keratinised. These two area are also highly vascular and most prone to trauma. The major protective effect of male circumcision can best be explained by the removal of most HIV receptor sites in the foreskin and frenulum.
Ref: McCoombe SG, Cameron PU, Short RV - How HIV enters the human penis. Int Conf AIDS. 2004 Jul 11-16;15:Abstract No. MoPeA3048.
040810
IB040507-21
©2004. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.